About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-TV
A1630G
A1630G-F3
A1630G-F2
A1630G-F1
A1636G
A1640G
A1640G-F1
C1624T
C1624T-F2
C1624T-F1
G1606A
G1606A-F1
G1608A
G1642A
G1644A
G1644T-F1
G1644A-F3
G1644T
T1659C
T1659C-F1
Edit by Mitofam Team
-
+
首页
G1642A
# **General Information** | **Position** | **1642** | **Variant** | **m.1642G\>A** | **Locus** | **MT\-TV** | **RNA** | **tRNA Val** | | --- | --- | --- | --- | --- | --- | --- | --- | | **Homoplasmy** | \- | **Heteroplasmy** | \+ | **mitoTIP** | 74\.30% | **Pathogenicity** | Reported | "Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/). # **Pedigree Information** The **m.1642G\>A** variant in MT\-TV has been reported in 2 pedigrees. To date, 2 carriers have been reported. Reported mutation loads ranged from 54% to 94%, with a median of 70% overall; affected carriers showed mutation loads from 54% to 94%, with a median of 70%. The main clinical manifestations among affected carriers included MELAS. | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 1642 | m.1642G\>A | G1642A\-F1 | UK | MELAS | ND | ND | 1996 | [8797538](https://pubmed.ncbi.nlm.nih.gov/8797538/) | | | 2 | 1642 | m.1642G\>A | G1642A\-F2 | Netherlands | MELAS | 1 | 0 | 1998 | [9443499](https://pubmed.ncbi.nlm.nih.gov/9443499/) | | # **Carrier Information** | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 1642 | m.1642G\>A | G1642A\-F1 | G1642A\-F1\-Ⅱ\-1 | Fam | M | Y | Y | A | 9 | 54% | 94% | / | / | MELAS | | | 2 | 1642 | m.1642G\>A | G1642A\-F2 | G1642A\-F2\-Ⅱ\-1 | De novo | M | Y | Y | D | 10 | 60% | 80% | / | / | MELAS | | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoying Chen
2026年6月25日 17:44
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)